Drugmakers Race to Develop New Weight Loss Treatments

Pharmaceutical giants and biotech firms are advancing a new wave of oral and injectable obesity treatments to challenge the dominance of Novo Nordisk and Eli Lilly. Analysts expect annual sector sales to reach 100 billion dollars within the next decade as clinical trials show significant weight loss results.